Triple negative breast cancer (TNBC) is an aggressive and heterogeneous subtype of breast cancer defined by the absence of estrogen (ER) and progesterone (PR) steroid hormone receptor expression and lacking high expression and/or amplification of HER2/ERBB2. This evidence concerns the gene ERBB2 and breast carcinoma.